APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical & Biotechnology IP Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharmaceutical & Biotechnology IP Services Industry Growth and Trends Forecast to 2032

21 December 2025111 pages

Choose your research edition.

Industry ResearchPharmaceutical & Biotechnology IP Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical & Biotechnology IP Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical & Biotechnology IP Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical & Biotechnology IP Services Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical & Biotechnology IP Services Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Pharmaceutical & Biotechnology IP Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmaceutical & Biotechnology IP Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical & Biotechnology IP Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical & Biotechnology IP Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pharmaceutical & Biotechnology IP Services market include Finnegan, MBHB, Wolf Greenfield & Sacks, P.C., Kirkland & Ellis LLP, Sterne Kessler, Nelson Mullins Riley & Scarborough LLP, Pabst Patent Group, Excelon IP and Pharma Patents International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmaceutical & Biotechnology IP Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmaceutical & Biotechnology IP Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical & Biotechnology IP Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical & Biotechnology IP Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pharmaceutical & Biotechnology IP Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmaceutical & Biotechnology IP Services Market by Company

Finnegan

MBHB

Wolf Greenfield & Sacks, P.C.

Kirkland & Ellis LLP

Sterne Kessler

Nelson Mullins Riley & Scarborough LLP

Pabst Patent Group

Excelon IP

Pharma Patents International

J A Kemp

DLA Piper

Michael Best & Friedrich LLP

Troutman Pepper

Cooley LLP

Fish & Richardson

Pharmaceutical & Biotechnology IP Services Segment by Type

Patents

Copyrights

Trademarks

Others

Pharmaceutical & Biotechnology IP Services Segment by Application

Pharmaceutical Companies

Contract Research Organizations (CROs)

Others

Pharmaceutical & Biotechnology IP Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical & Biotechnology IP Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical & Biotechnology IP Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical & Biotechnology IP Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pharmaceutical & Biotechnology IP Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical & Biotechnology IP Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pharmaceutical & Biotechnology IP Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pharmaceutical & Biotechnology IP Services Market Share by Region (2021-2026) Table 4. Global Pharmaceutical & Biotechnology IP Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pharmaceutical & Biotechnology IP Services Market Share by Region (2027-2032) Table 6. Global Pharmaceutical & Biotechnology IP Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pharmaceutical & Biotechnology IP Services Market Size Share by Type (2021-2026) Table 9. Global Pharmaceutical & Biotechnology IP Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pharmaceutical & Biotechnology IP Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical & Biotechnology IP Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pharmaceutical & Biotechnology IP Services Market Size Share by Application (2021-2026) Table 24. Global Pharmaceutical & Biotechnology IP Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pharmaceutical & Biotechnology IP Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pharmaceutical & Biotechnology IP Services Industry Trends Table 37. Pharmaceutical & Biotechnology IP Services Industry Drivers Table 38. Pharmaceutical & Biotechnology IP Services Industry Opportunities and Challenges Table 39. Pharmaceutical & Biotechnology IP Services Industry Restraints Table 40. Global Pharmaceutical & Biotechnology IP Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Company (2021-2026) Table 42. Global Pharmaceutical & Biotechnology IP Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pharmaceutical & Biotechnology IP Services Key Company Headquarters & Area Served Table 44. Global Pharmaceutical & Biotechnology IP Services Company, Product Type & Application Table 45. Global Pharmaceutical & Biotechnology IP Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pharmaceutical & Biotechnology IP Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Finnegan Company Information Table 49. Finnegan Business Overview Table 50. Finnegan Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Finnegan Pharmaceutical & Biotechnology IP Services Product Portfolio Table 52. Finnegan Recent Development Table 53. MBHB Company Information Table 54. MBHB Business Overview Table 55. MBHB Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. MBHB Pharmaceutical & Biotechnology IP Services Product Portfolio Table 57. MBHB Recent Development Table 58. Wolf Greenfield & Sacks, P.C. Company Information Table 59. Wolf Greenfield & Sacks, P.C. Business Overview Table 60. Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Product Portfolio Table 62. Wolf Greenfield & Sacks, P.C. Recent Development Table 63. Kirkland & Ellis LLP Company Information Table 64. Kirkland & Ellis LLP Business Overview Table 65. Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 67. Kirkland & Ellis LLP Recent Development Table 68. Sterne Kessler Company Information Table 69. Sterne Kessler Business Overview Table 70. Sterne Kessler Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sterne Kessler Pharmaceutical & Biotechnology IP Services Product Portfolio Table 72. Sterne Kessler Recent Development Table 73. Nelson Mullins Riley & Scarborough LLP Company Information Table 74. Nelson Mullins Riley & Scarborough LLP Business Overview Table 75. Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 77. Nelson Mullins Riley & Scarborough LLP Recent Development Table 78. Pabst Patent Group Company Information Table 79. Pabst Patent Group Business Overview Table 80. Pabst Patent Group Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pabst Patent Group Pharmaceutical & Biotechnology IP Services Product Portfolio Table 82. Pabst Patent Group Recent Development Table 83. Excelon IP Company Information Table 84. Excelon IP Business Overview Table 85. Excelon IP Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Excelon IP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 87. Excelon IP Recent Development Table 88. Pharma Patents International Company Information Table 89. Pharma Patents International Business Overview Table 90. Pharma Patents International Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pharma Patents International Pharmaceutical & Biotechnology IP Services Product Portfolio Table 92. Pharma Patents International Recent Development Table 93. J A Kemp Company Information Table 94. J A Kemp Business Overview Table 95. J A Kemp Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. J A Kemp Pharmaceutical & Biotechnology IP Services Product Portfolio Table 97. J A Kemp Recent Development Table 98. DLA Piper Company Information Table 99. DLA Piper Business Overview Table 100. DLA Piper Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. DLA Piper Pharmaceutical & Biotechnology IP Services Product Portfolio Table 102. DLA Piper Recent Development Table 103. Michael Best & Friedrich LLP Company Information Table 104. Michael Best & Friedrich LLP Business Overview Table 105. Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 107. Michael Best & Friedrich LLP Recent Development Table 108. Troutman Pepper Company Information Table 109. Troutman Pepper Business Overview Table 110. Troutman Pepper Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Troutman Pepper Pharmaceutical & Biotechnology IP Services Product Portfolio Table 112. Troutman Pepper Recent Development Table 113. Cooley LLP Company Information Table 114. Cooley LLP Business Overview Table 115. Cooley LLP Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Cooley LLP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 117. Cooley LLP Recent Development Table 118. Fish & Richardson Company Information Table 119. Fish & Richardson Business Overview Table 120. Fish & Richardson Pharmaceutical & Biotechnology IP Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Fish & Richardson Pharmaceutical & Biotechnology IP Services Product Portfolio Table 122. Fish & Richardson Recent Development Table 123. North America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2026) Table 126. North America Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Pharmaceutical & Biotechnology IP Services Market Share Forecast by Country (2027-2032) Table 128. Europe Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2026) Table 131. Europe Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Pharmaceutical & Biotechnology IP Services Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2026) Table 136. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Share Forecast by Country (2027-2032) Table 138. Latin America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2026) Table 141. Latin America Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Pharmaceutical & Biotechnology IP Services Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2026) Table 146. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pharmaceutical & Biotechnology IP Services Product Image Figure 3. Global Pharmaceutical & Biotechnology IP Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Pharmaceutical & Biotechnology IP Services Market Share by Region: 2025 VS 2032 Figure 6. Global Pharmaceutical & Biotechnology IP Services Market Share by Region (2021-2032) Figure 7. North America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Patents Image Figure 13. Global Patents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Copyrights Image Figure 15. Global Copyrights Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Trademarks Image Figure 17. Global Trademarks Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Pharmaceutical & Biotechnology IP Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Pharmaceutical & Biotechnology IP Services Market Share by Type 2025 VS 2032 Figure 22. North America Pharmaceutical & Biotechnology IP Services Market Size Share by Type (2021-2032) Figure 23. Europe Pharmaceutical & Biotechnology IP Services Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Share by Type (2021-2032) Figure 25. Latin America Pharmaceutical & Biotechnology IP Services Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Pharmaceutical & Biotechnology IP Services Market Size Share by Type (2021-2032) Figure 27. Pharmaceutical Companies Image Figure 28. Global Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Contract Research Organizations (CROs) Image Figure 30. Global Contract Research Organizations (CROs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Pharmaceutical & Biotechnology IP Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Pharmaceutical & Biotechnology IP Services Market Share by Application 2025 VS 2032 Figure 35. North America Pharmaceutical & Biotechnology IP Services Market Size Share by Application (2021-2032) Figure 36. Europe Pharmaceutical & Biotechnology IP Services Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Share by Application (2021-2032) Figure 38. Latin America Pharmaceutical & Biotechnology IP Services Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Pharmaceutical & Biotechnology IP Services Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Pharmaceutical & Biotechnology IP Services Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Pharmaceutical & Biotechnology IP Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Pharmaceutical & Biotechnology IP Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032) Figure 45. Europe Pharmaceutical & Biotechnology IP Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Pharmaceutical & Biotechnology IP Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032) Figure 48. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032) Figure 51. Latin America Pharmaceutical & Biotechnology IP Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Pharmaceutical & Biotechnology IP Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032) Figure 54. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Patents
  • Copyrights
  • Trademarks
  • Others
Applications
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others
Companies covered
  • Finnegan
  • MBHB
  • Wolf Greenfield & Sacks, P.C.
  • Kirkland & Ellis LLP
  • Sterne Kessler
  • Nelson Mullins Riley & Scarborough LLP
  • Pabst Patent Group
  • Excelon IP
  • Pharma Patents International
  • J A Kemp
  • DLA Piper
  • Michael Best & Friedrich LLP
  • Troutman Pepper
  • Cooley LLP
  • Fish & Richardson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pharmaceutical & Biotechnology IP Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pharmaceutical & Biotechnology IP Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Pharmaceutical & Biotechnology IP Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Pharmaceutical & Biotechnology IP Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pharmaceutical & Biotechnology IP Services Market Size (2021-2032)
  8. 1.5.1 North America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (2021-2032)
2 Pharmaceutical & Biotechnology IP Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Patents
  3. 2.1.2 Copyrights
  4. 2.1.3 Trademarks
  5. 2.1.4 Others
  6. 2.2 Global Pharmaceutical & Biotechnology IP Services Market Size by Type
  7. 2.2.1 Global Pharmaceutical & Biotechnology IP Services Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Pharmaceutical & Biotechnology IP Services Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Pharmaceutical & Biotechnology IP Services Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Pharmaceutical & Biotechnology IP Services Market Size by Regions
  11. 2.3.1 North America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical & Biotechnology IP Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Companies
  3. 3.1.2 Contract Research Organizations (CROs)
  4. 3.1.3 Others
  5. 3.2 Global Pharmaceutical & Biotechnology IP Services Market Size by Application
  6. 3.2.1 Global Pharmaceutical & Biotechnology IP Services Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Pharmaceutical & Biotechnology IP Services Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Pharmaceutical & Biotechnology IP Services Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Pharmaceutical & Biotechnology IP Services Market Size by Regions
  10. 3.3.1 North America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Pharmaceutical & Biotechnology IP Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pharmaceutical & Biotechnology IP Services Industry Trends
  2. 4.2 Pharmaceutical & Biotechnology IP Services Industry Drivers
  3. 4.3 Pharmaceutical & Biotechnology IP Services Industry Opportunities and Challenges
  4. 4.4 Pharmaceutical & Biotechnology IP Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pharmaceutical & Biotechnology IP Services Revenue (2021-2026)
  2. 5.2 Global Pharmaceutical & Biotechnology IP Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pharmaceutical & Biotechnology IP Services Key Company Headquarters & Area Served
  4. 5.4 Global Pharmaceutical & Biotechnology IP Services Company, Product Type & Application
  5. 5.5 Global Pharmaceutical & Biotechnology IP Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pharmaceutical & Biotechnology IP Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pharmaceutical & Biotechnology IP Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pharmaceutical & Biotechnology IP Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Finnegan
  2. 6.1.1 Finnegan Company Information
  3. 6.1.2 Finnegan Business Overview
  4. 6.1.3 Finnegan Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Finnegan Pharmaceutical & Biotechnology IP Services Product Portfolio
  6. 6.1.5 Finnegan Recent Developments
  7. 6.2 MBHB
  8. 6.2.1 MBHB Company Information
  9. 6.2.2 MBHB Business Overview
  10. 6.2.3 MBHB Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 MBHB Pharmaceutical & Biotechnology IP Services Product Portfolio
  12. 6.2.5 MBHB Recent Developments
  13. 6.3 Wolf Greenfield & Sacks, P.C.
  14. 6.3.1 Wolf Greenfield & Sacks, P.C. Company Information
  15. 6.3.2 Wolf Greenfield & Sacks, P.C. Business Overview
  16. 6.3.3 Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Product Portfolio
  18. 6.3.5 Wolf Greenfield & Sacks, P.C. Recent Developments
  19. 6.4 Kirkland & Ellis LLP
  20. 6.4.1 Kirkland & Ellis LLP Company Information
  21. 6.4.2 Kirkland & Ellis LLP Business Overview
  22. 6.4.3 Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Product Portfolio
  24. 6.4.5 Kirkland & Ellis LLP Recent Developments
  25. 6.5 Sterne Kessler
  26. 6.5.1 Sterne Kessler Company Information
  27. 6.5.2 Sterne Kessler Business Overview
  28. 6.5.3 Sterne Kessler Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sterne Kessler Pharmaceutical & Biotechnology IP Services Product Portfolio
  30. 6.5.5 Sterne Kessler Recent Developments
  31. 6.6 Nelson Mullins Riley & Scarborough LLP
  32. 6.6.1 Nelson Mullins Riley & Scarborough LLP Company Information
  33. 6.6.2 Nelson Mullins Riley & Scarborough LLP Business Overview
  34. 6.6.3 Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Product Portfolio
  36. 6.6.5 Nelson Mullins Riley & Scarborough LLP Recent Developments
  37. 6.7 Pabst Patent Group
  38. 6.7.1 Pabst Patent Group Company Information
  39. 6.7.2 Pabst Patent Group Business Overview
  40. 6.7.3 Pabst Patent Group Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pabst Patent Group Pharmaceutical & Biotechnology IP Services Product Portfolio
  42. 6.7.5 Pabst Patent Group Recent Developments
  43. 6.8 Excelon IP
  44. 6.8.1 Excelon IP Company Information
  45. 6.8.2 Excelon IP Business Overview
  46. 6.8.3 Excelon IP Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Excelon IP Pharmaceutical & Biotechnology IP Services Product Portfolio
  48. 6.8.5 Excelon IP Recent Developments
  49. 6.9 Pharma Patents International
  50. 6.9.1 Pharma Patents International Company Information
  51. 6.9.2 Pharma Patents International Business Overview
  52. 6.9.3 Pharma Patents International Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pharma Patents International Pharmaceutical & Biotechnology IP Services Product Portfolio
  54. 6.9.5 Pharma Patents International Recent Developments
  55. 6.10 J A Kemp
  56. 6.10.1 J A Kemp Company Information
  57. 6.10.2 J A Kemp Business Overview
  58. 6.10.3 J A Kemp Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 J A Kemp Pharmaceutical & Biotechnology IP Services Product Portfolio
  60. 6.10.5 J A Kemp Recent Developments
  61. 6.11 DLA Piper
  62. 6.11.1 DLA Piper Company Information
  63. 6.11.2 DLA Piper Business Overview
  64. 6.11.3 DLA Piper Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 DLA Piper Pharmaceutical & Biotechnology IP Services Product Portfolio
  66. 6.11.5 DLA Piper Recent Developments
  67. 6.12 Michael Best & Friedrich LLP
  68. 6.12.1 Michael Best & Friedrich LLP Company Information
  69. 6.12.2 Michael Best & Friedrich LLP Business Overview
  70. 6.12.3 Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Product Portfolio
  72. 6.12.5 Michael Best & Friedrich LLP Recent Developments
  73. 6.13 Troutman Pepper
  74. 6.13.1 Troutman Pepper Company Information
  75. 6.13.2 Troutman Pepper Business Overview
  76. 6.13.3 Troutman Pepper Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Troutman Pepper Pharmaceutical & Biotechnology IP Services Product Portfolio
  78. 6.13.5 Troutman Pepper Recent Developments
  79. 6.14 Cooley LLP
  80. 6.14.1 Cooley LLP Company Information
  81. 6.14.2 Cooley LLP Business Overview
  82. 6.14.3 Cooley LLP Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Cooley LLP Pharmaceutical & Biotechnology IP Services Product Portfolio
  84. 6.14.5 Cooley LLP Recent Developments
  85. 6.15 Fish & Richardson
  86. 6.15.1 Fish & Richardson Company Information
  87. 6.15.2 Fish & Richardson Business Overview
  88. 6.15.3 Fish & Richardson Pharmaceutical & Biotechnology IP Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Fish & Richardson Pharmaceutical & Biotechnology IP Services Product Portfolio
  90. 6.15.5 Fish & Richardson Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026)
  3. 7.3 North America Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026)
  3. 8.3 Europe Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026)
  3. 10.3 South America Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst